David Baltimore

Dr. David Baltimore was previously employed as a Chairman & Co-Scientific Founder by Appia Bio, Inc., an Independent Director by Regulus Therapeutics, Inc., a Chairman & President by American Association for the Advancement of Science, a Founder by Helixis, Inc., a President-Emeritus & Professor-Biology by California Institute of Technology, an Independent Director by Amgen, Inc., a President by Caltech Industries, Inc., an Independent Director by Immune Design Corp., a Vice Chairman by BB Biotech AG, a Professor by The Rockefeller University, a Professor by American Cancer Society California Division, Inc., a Professor by Massachusetts Institute of Technology, an Independent Director by Altos Labs, Inc., a Member by Human Genome Organisation, a Chairman by MPM Capital LLC, a Science Partner by The Column Group LLC, a Vice Chairman by The Damon Runyon Cancer Research Foundation, a Trustee-Emeritus by The Jackson Laboratory, and a Director & Member by Whitehead Institute for Biomedical Research.
He also served on the board at Calimmune, Inc., MedImmune LLC, FasterCures, Foundation for Biomedical Research, The Broad Institute, Inc. and The Broad Foundations.
He received his undergraduate degree from Swarthmore College and a doctorate degree from The Rockefeller University.